Investing.com -- Anixa Biosciences Inc. (NASDAQ:ANIX) stock gained 2.2% in premarket trading Monday after the company announced it received a Chinese patent for its breast cancer vaccine technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback